TGFB1 and neoplasm: This comprised analyses showing that platelet-derived TGF-β downregulates the activating receptor NKG2D on NK cells [12] and that NKG2D ligands are shed from the tumor cell surface following tumor-platelet interaction [13], thereby facilitating evasion from the NK cell “induced self” recognition mode [14].